A Kerala BioPharma company gets DCGI nod for Phase-2 clinical trial for novel drug to treat COVID-19
The 9-year, startup, PNB Vesper Lifesciences claims its PNB-001, a molecule that can reduce pro-inflammatory cytokines (IL-6), is the world’s first novel chemical entity to treat COVID-19. The molecule development has been funded by BIRAC under government of India.
Affigenix get regulatory nod to make 3 COVID-19 home-made diagnostic kits
ABLE member, Affigenix Biosolutions, a startup based in Bangalore, can now start manufacture and sale of three diagnostic kits, Affimag, Affispin and Affigenix COVID-19 test (ACT) RT-QPCR kits for diagnosis of COVID-19.
Genotypic brings Israeli Smart pooling solution to India to ramp-up COVID19 screening
The Smart one-step pooling technology, using an advanced mathematic algorithm, developed by Tel Aviv-based Less Tests could significantly reduce costs and increase number of tests being done daily